FUNDACION INCIENSA

FUNDACION INCIENSA specializes in longitudinal epidemiological research and public health follow-up studies focused on infectious disease prevention, with deep expertise in human papillomavirus (HPV) vaccine efficacy, cervical disease screening, and biospecimen analysis. The contractor designs and executes complex, multi-year cohort studies, managing end-to-end participant engagement—from initial recruitment and clinical screenings to longitudinal follow-up, data collection, and laboratory coordination. Their technical capabilities include protocol development for non-inferiority trials, standardized diagnostic and treatment procedures for cervical pathology, electronic data management systems, and biospecimen handling aligned with NCI and HHS protocols. A key differentiator is their sustained operational continuity in extended follow-up programs, ensuring data integrity across extended timeframes and enabling robust real-world evidence generation for vaccine durability and public health impact. The contractor maintains a consistent, long-term relationship with the Department of Health and Human Services, delivering research support for large-scale infectious disease prevention initiatives. Their work spans epidemiological surveillance, clinical trial logistics, and translational research activities, often serving as the operational backbone for multi-site studies requiring precise participant tracking and biospecimen chain-of-custody protocols. Their primary industry focus is research and development in the social sciences and humanities, specifically applied to public health outcomes. In practice, this translates to behavioral, clinical, and epidemiological research that informs national immunization policies and cancer prevention strategies, positioning them as a niche provider of human-centered health research services within the federal biomedical research ecosystem. FUNDACION INCIENSA is structured as an X6 entity based in La Union, San Jose, with no government certifications disclosed. Their geographic presence is localized, yet their contract scope is nationally aligned with U.S. federal health research priorities, indicating a specialized, mission-driven role within the broader public health research infrastructure.